Marcielle C de Beer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Marcielle C de Beer has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
Deneys R. van der Westhuyzen
Graduate Center for Nutritional Science, University of Kentucky Medical Center, Lexington, KY 40536
5 shared publicationsJoanne M. Wroblewski
Graduate Center for Nutritional Science, University of Kentucky Medical Center, Lexington, KY 40536
4 shared publicationsNancy R. Webb
Graduate Center for Nutritional Science, University of Kentucky Medical Center, Lexington, KY 40536
4 shared publicationsAiling Ji
Graduate Center for Nutritional Science, University of Kentucky Medical Center, Lexington, KY 40536
3 shared publicationsFrederick C. de Beer
†Internal Medicine, University of Kentucky Medical Center, Lexington, KY
3 shared publicationsVictoria P. Noffsinger
Graduate Center for Nutritional Science, University of Kentucky Medical Center, Lexington, KY 40536
3 shared publications
Latest Publications
- Open Access
- 1 March 2020
- Published by Elsevier in Journal of Lipid Research
- Vol. 61 (3) , 328-337
Serum amyloid A is not incorporated into HDL during HDL biogenesis
- 1 March 2020
- Published by Elsevier in Journal of Lipid Research
- Vol. 61 (3) , 328-337
Open AccessSerum amyloid A is not incorporated into HDL during HDL biogenesis
- 1 February 2014
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 34 (2) , 255-261
Deficiency of Endogenous Acute Phase Serum Amyloid A Does Not Affect Atherosclerotic Lesions in Apolipoprotein E–Deficient Mice
Objective—: Although elevated plasma concentrations of serum amyloid A (SAA) are associated strongly with increased risk for atherosclerotic cardiovascular disease in humans, the role of SAA in the pathogenesis of lesion formation remains obscure. Our goal was to determine the impact of SAA deficiency on atherosclerosis in hypercholesterolemic mice. Approach and Results—: Apolipoprotein E–deficient (apoE −/− ) mice, either wild type or deficient in both major acute phase SAA isoforms, SAA1.1 and SAA2.1, were fed a normal rodent diet for 50 weeks. Female mice, but not male apoE−/− mice deficient in SAA1.1 and SAA2.1, had a modest increase (22%; P ≤0.05) in plasma cholesterol concentrations and a 53% increase in adipose mass compared with apoE−/− mice expressing SAA1.1 and SAA2.1 that did not affect the plasma cytokine levels or the expression of adipose tissue inflammatory markers. SAA deficiency did not affect lipoprotein cholesterol distributions or plasma triglyceride concentrations in either male or female mice. Atherosclerotic lesion areas measured on the intimal surfaces of the arch, thoracic, and abdominal regions were not significantly different between apoE−/− mice deficient in SAA1.1 and SAA2.1 and apoE−/− mice expressing SAA1.1 and SAA2.1 in either sex. To accelerate lesion formation, mice were fed a Western diet for 12 weeks. SAA deficiency had effect neither on diet-induced alterations in plasma cholesterol, triglyceride, or cytokine concentrations nor on aortic atherosclerotic lesion areas in either male or female mice. In addition, SAA deficiency in male mice had no effect on lesion areas or macrophage accumulation in the aortic roots. Conclusions—: The absence of endogenous SAA1.1 and 2.1 does not affect atherosclerotic lipid deposition in apolipoprotein E–deficient mice fed either normal or Western diets.
- 1 February 2014
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 34 (2) , 255-261
Deficiency of Endogenous Acute Phase Serum Amyloid A Does Not Affect Atherosclerotic Lesions in Apolipoprotein E–Deficient Mice
Objective—: Although elevated plasma concentrations of serum amyloid A (SAA) are associated strongly with increased risk for atherosclerotic cardiovascular disease in humans, the role of SAA in the pathogenesis of lesion formation remains obscure. Our goal was to determine the impact of SAA deficiency on atherosclerosis in hypercholesterolemic mice. Approach and Results—: Apolipoprotein E–deficient (apoE −/− ) mice, either wild type or deficient in both major acute phase SAA isoforms, SAA1.1 and SAA2.1, were fed a normal rodent diet for 50 weeks. Female mice, but not male apoE−/− mice deficient in SAA1.1 and SAA2.1, had a modest increase (22%; P ≤0.05) in plasma cholesterol concentrations and a 53% increase in adipose mass compared with apoE−/− mice expressing SAA1.1 and SAA2.1 that did not affect the plasma cytokine levels or the expression of adipose tissue inflammatory markers. SAA deficiency did not affect lipoprotein cholesterol distributions or plasma triglyceride concentrations in either male or female mice. Atherosclerotic lesion areas measured on the intimal surfaces of the arch, thoracic, and abdominal regions were not significantly different between apoE−/− mice deficient in SAA1.1 and SAA2.1 and apoE−/− mice expressing SAA1.1 and SAA2.1 in either sex. To accelerate lesion formation, mice were fed a Western diet for 12 weeks. SAA deficiency had effect neither on diet-induced alterations in plasma cholesterol, triglyceride, or cytokine concentrations nor on aortic atherosclerotic lesion areas in either male or female mice. In addition, SAA deficiency in male mice had no effect on lesion areas or macrophage accumulation in the aortic roots. Conclusions—: The absence of endogenous SAA1.1 and 2.1 does not affect atherosclerotic lipid deposition in apolipoprotein E–deficient mice fed either normal or Western diets.
- Open Access
- 1 January 2013
- Published by Wiley in Journal of Lipids
- Vol. 2013, 1-11
The Impairment of Macrophage-to-Feces Reverse Cholesterol Transport during Inflammation Does Not Depend on Serum Amyloid A
Studies suggest that inflammation impairs reverse cholesterol transport (RCT). We investigated whether serum amyloid A (SAA) contributes to this impairment using an established macrophage-to-feces RCT model. Wild-type (WT) mice and mice deficient in SAA1.1 and SAA2.1 (SAAKO) were injected intraperitoneally with3H-cholesterol-labeled J774 macrophages 4 hr after administration of LPS or buffered saline.3H-cholesterol in plasma 4 hr after macrophage injection was significantly reduced in both WT and SAAKO mice injected with LPS, but this was not associated with a reduced capacity of serum from LPS-injected mice to promote macrophage cholesterol effluxin vitro. Hepatic accumulation of3H-cholesterol was unaltered in either WT or SAAKO mice by LPS treatment. Radioactivity present in bile and feces of LPS-injected WT mice 24 hr after macrophage injection was reduced by 36% and 80% , respectively. In contrast, in SAAKO mice, LPS did not significantly reduce macrophage-derived3H-cholesterol in bile, and fecal excretion was reduced by only 45% . Injection of cholesterol-loaded allogeneic J774 cells, but not syngeneic bone-marrow-derived macrophages, transiently induced SAA in C57BL/6 mice. Our study confirms reports that acute inflammation impairs steps in the RCT pathway and establishes that SAA plays only a minor role in this impairment.- 1 January 2013
- Published by Wiley in Journal of Lipids
- Vol. 2013, 1-11
Open AccessThe Impairment of Macrophage-to-Feces Reverse Cholesterol Transport during Inflammation Does Not Depend on Serum Amyloid A
Studies suggest that inflammation impairs reverse cholesterol transport (RCT). We investigated whether serum amyloid A (SAA) contributes to this impairment using an established macrophage-to-feces RCT model. Wild-type (WT) mice and mice deficient in SAA1.1 and SAA2.1 (SAAKO) were injected intraperitoneally with3H-cholesterol-labeled J774 macrophages 4 hr after administration of LPS or buffered saline.3H-cholesterol in plasma 4 hr after macrophage injection was significantly reduced in both WT and SAAKO mice injected with LPS, but this was not associated with a reduced capacity of serum from LPS-injected mice to promote macrophage cholesterol effluxin vitro. Hepatic accumulation of3H-cholesterol was unaltered in either WT or SAAKO mice by LPS treatment. Radioactivity present in bile and feces of LPS-injected WT mice 24 hr after macrophage injection was reduced by 36% and 80% , respectively. In contrast, in SAAKO mice, LPS did not significantly reduce macrophage-derived3H-cholesterol in bile, and fecal excretion was reduced by only 45% . Injection of cholesterol-loaded allogeneic J774 cells, but not syngeneic bone-marrow-derived macrophages, transiently induced SAA in C57BL/6 mice. Our study confirms reports that acute inflammation impairs steps in the RCT pathway and establishes that SAA plays only a minor role in this impairment. - 1 July 2011
- Published by Elsevier in Atherosclerosis
- Vol. 217 (1) , 106-112
Scavenger receptor SR-BI in macrophage lipid metabolism
- 1 July 2011
- Published by Elsevier in Atherosclerosis
- Vol. 217 (1) , 106-112
Scavenger receptor SR-BI in macrophage lipid metabolism
- Open Access
- 1 February 2011
- Published by Elsevier in Journal of Lipid Research
- Vol. 52 (2) , 345-353
ATP binding cassette G1-dependent cholesterol efflux during inflammation
- 1 February 2011
- Published by Elsevier in Journal of Lipid Research
- Vol. 52 (2) , 345-353
Open AccessATP binding cassette G1-dependent cholesterol efflux during inflammation
- Open Access
- 10 November 2010
- Published by Springer Nature in BMC Gastroenterology
- Vol. 10 (1) , 133
Intestinal Epithelial Serum Amyloid A Modulates Bacterial Growth In Vitro and Pro-Inflammatory Responses in Mouse Experimental Colitis
Serum Amyloid A (SAA) is a major acute phase protein of unknown function. SAA is mostly expressed in the liver, but also in other tissues including the intestinal epithelium. SAA reportedly has anti-bacterial effects, and because inflammatory bowel diseases (IBD) result from a breakdown in homeostatic interactions between intestinal epithelia and bacteria, we hypothesized that SAA is protective during experimental colitis.
- 10 November 2010
- Published by Springer Nature in BMC Gastroenterology
- Vol. 10 (1) , 133
Open AccessIntestinal Epithelial Serum Amyloid A Modulates Bacterial Growth In Vitro and Pro-Inflammatory Responses in Mouse Experimental Colitis
Serum Amyloid A (SAA) is a major acute phase protein of unknown function. SAA is mostly expressed in the liver, but also in other tissues including the intestinal epithelium. SAA reportedly has anti-bacterial effects, and because inflammatory bowel diseases (IBD) result from a breakdown in homeostatic interactions between intestinal epithelia and bacteria, we hypothesized that SAA is protective during experimental colitis.
- Open Access
- 1 November 2010
- Published by Elsevier in Journal of Lipid Research
- Vol. 51 (11) , 3117-3125
Impact of serum amyloid A on high density lipoprotein composition and levels
- 1 November 2010
- Published by Elsevier in Journal of Lipid Research
- Vol. 51 (11) , 3117-3125
Open AccessImpact of serum amyloid A on high density lipoprotein composition and levels
- 1 September 2009
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 29 (9) , 1298-1303
SR-BI Selective Lipid Uptake
Objective— The purpose of this study was to investigate the interaction of SAA and SR-BI in remodeling of acute phase HDL (AP HDL). Methods and Results— We used SAA and SR-BI adenoviral vector expression models to study the interaction between these entities. SR-BI processing of mouse AP HDL generated progressively smaller discreet HDL particles with distinct apolipoprotein compositions. SR-BI actions segregated apolipoproteins with the smallest particles containing only apoA-I. Larger remnants contained apoA-I, apoA-II, and SAA. Small apoA-I only particles failed to associate with preformed HDL, whereas larger remnants readily did. The presence of SAA on SR-BI-processed HDL particles propelled apoA-I to a small lipid-poor form and accelerated apoA-I catabolism. Conclusions— Data indicate that after core and surface HDL lipid perturbation by SR-BI, SAA propels apoA-I to a small lipid-poor form while accelerating HDL metabolism.
- 1 September 2009
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 29 (9) , 1298-1303
SR-BI Selective Lipid Uptake
Objective— The purpose of this study was to investigate the interaction of SAA and SR-BI in remodeling of acute phase HDL (AP HDL). Methods and Results— We used SAA and SR-BI adenoviral vector expression models to study the interaction between these entities. SR-BI processing of mouse AP HDL generated progressively smaller discreet HDL particles with distinct apolipoprotein compositions. SR-BI actions segregated apolipoproteins with the smallest particles containing only apoA-I. Larger remnants contained apoA-I, apoA-II, and SAA. Small apoA-I only particles failed to associate with preformed HDL, whereas larger remnants readily did. The presence of SAA on SR-BI-processed HDL particles propelled apoA-I to a small lipid-poor form and accelerated apoA-I catabolism. Conclusions— Data indicate that after core and surface HDL lipid perturbation by SR-BI, SAA propels apoA-I to a small lipid-poor form while accelerating HDL metabolism.